Symbol
| CSNK2A1
| contributors: mct - updated : 26-02-2015
|
HGNC name
| casein kinase 2, alpha 1 polypeptide
|
HGNC id
| 2457
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
associated with hyperproliferation and suppression of apoptosis in cancer | constitutional
|  
|  
|  
| loss of function
|
resulted in an elevated level of insulin secretion  | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | | |  |
selective CSNK2A1 inhibition or down-regulation in tumors may provide an attractive opportunity for the development of novel cancer therapies | cancer | | |  |
CSNK2A1 inhibitors, are potential therapies for multiple diseases that are driven by inflammation
|
| | | |